The forecast for alimentary tract and metabolism medicine sales in Italy shows a modest increase from 2024 to 2028, with values rising from 12.9 to 13.2. Compared to 2023, the year-on-year sales growth is relatively stable, reflecting a slight upward trend. The compound annual growth rate (CAGR) over the five-year period indicates a gradual but consistent increase.
Future trends to watch for:
- Advancements in medical research and personalized medicine may drive demand.
- Regulatory changes and healthcare reforms could impact sales dynamics.
- Population aging in Italy may increase demand for these medicines.
- Innovation in treatments could alter market dynamics significantly.